QuoTrend
DashboardScreenCompareStrategiesPortfolioSectorsHeatmapsInsiderFuturesForexCryptoCalendarNews
DashboardScreenCompareStrategiesPortfolioSectorsHeatmapsInsiderFuturesForexCryptoCalendarNewsMore
⌘K
Help
QuoTrend
PAGEHome
HomePricingContactHelpTermsPrivacy
Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
© 2026 QuoTrend
Screen

USPH

QT60U.S. Physical Therapy, Inc.
NYSE·Healthcare·Medical - Care Facilities·USA
Latest market price
63.32
+0.48+0.76%
OverviewShort InterestFilings
USPHQT60U.S. Physical Therapy, Inc.·NYSE
OverviewShort InterestFilings
63.32+0.76%
TA
Loading chart...
Screen all →
HCA-3.35%$375.17THC-3.32%$172.57DVA-1.27%$207.91SOLV+1.17%$75.43FMS+0.08%$23.59EHC+0.14%$98.03ENSG-1.41%$153.65UHS-0.06%$141.17
Snapshot
Index-P/E807.71EPS (ttm)0.50
Insider Own5.58%
Shs Outstand15.22M
Perf Week-3.75%
Market Cap956.35MForward P/E18.48EPS next Y3.43Insider Trans-0.03%Shs Float-Perf Month2.78%
Enterprise Value1.29BPEG-EPS next Q0.85Inst Own-Short Float-Perf Quarter-14.81%
Income1.15MP/S1.31EPS this Y479.19%Inst Trans-Short Ratio-Perf Half Y-19.34%
Sales729.23MP/B2.03EPS next Y18.34%ROA0.10%Short Interest-Perf YTD-18.91%
Book/sh51.45P/C11.38EPS next 5Y11.50%ROE0.24%52W High93.50 -32.28%Perf Year-14.95%
Cash/sh1.84P/FCF14.30EPS past 3/5Y-ROIC5.49%52W Low58.19 8.82%Perf 3Y-
Dividend Est.-EV/EBITDA12.47Sales past 3/5Y12.20% 13.05%Gross Margin20.44%Volatility2.43% 2.50%Perf 5Y-
Dividend TTM-EV/Sales1.77EPS Y/Y TTM41.30%Oper. Margin11.96%ATR (14)2.55Perf 10Y-
Dividend Ex-Date-Quick Ratio1.19Sales Y/Y TTM8.64%Profit Margin0.16%RSI (14)46.27Recom2.23
Dividend Gr. 3/5Y-Current Ratio1.19EPS Q/Q-4.17%SMA20-0.02%Beta0.87Target Price96.00
Payout2318.81%Debt/Eq0.77Sales Q/Q29.41%SMA50-6.17%Rel Volume1.18Prev Close62.84
Employees4,034LT Debt/Eq0.49EarningsAug 05SMA200-18.70%Avg Volume214.57KPrice63.32
IPO DateMay 29, 1992Option/ShortYes / YesEPS/Sales Surpr.-16.36% -1.49%Net Debt/EBITDA3.23Volume253,926Change0.76%
Analyst Ratings
DateActionAnalystRatingTarget
May-13-26ReiteratedBarrington$103 → $90
Mar-09-26ReiteratedJefferiesBuy$102
Feb-28-25ReiteratedBarrington$108 → $98
Dec-16-24UpgradeB of A SecuritiesNeutral → Buy
Oct-07-24DowngradeB of A SecuritiesBuy → Neutral
Sep-19-23UpgradeCJS SecuritiesMarket Perform → Market Outperform
Dec-14-21UpgradeCJS SecuritiesMarket Perform → Market Outperform
May-07-21UpgradeBarrington ResearchMarket Perform → Outperform
May-03-21UpgradeJefferiesHold → Buy
Feb-26-21DowngradeBarrington ResearchOutperform → Market Perform
Latest News
Company
Ownership

Per-holder 13F data hasn't been ingested for this ticker yet.

Financial Statements
DataTimeframe
Line Item (USD, M)
TTM
—
FY 2025
12/31/2025
FY 2024
12/31/2024
FY 2023
12/31/2023
FY 2022
12/31/2022
FY 2021
12/31/2021
FY 2020
12/31/2020
FY 2019
12/31/2019
FY 2018
12/31/2018
Total Revenue729781671
Upgrade your experience to unlock full historical data
Cost of Goods Sold Incl. D&A581624547
Gross Profit150157124
Selling, General and Administrative Excl. Other31058
Research and Development
000
Other Operating Expense32773
Operating Income878063
Interest Expense998
Unusual Expense
———
Non-Operating Income (Expense)7-7-5
Net Income Before Taxes727860
Income Taxes182015
Consolidated Net Income11526
Net Income From Continuing Operations535846
Net Income11526
EPS (Recurring)0.501.421.84
EPS (Basic, Before Extraordinaries)0.501.421.84
EPS (Diluted)0.501.421.84
EBITDA10311087
Other After Tax Adjustments
———
Stock Option Compensation Expense
———
Price To Earnings Ratio126.6454.99—
Price To Sales Ratio1.301.50—
Gross Margin20.5820.1018.48
Operating Margin11.9310.249.39
Net Margin0.141.923.87
Shares Outstanding151515
Market Capitalization9501,171—
Operating Lease Expense
———
Insider Trading Volume
$67.90$63.01$58.12$53.23$48.34● Close Price0.00K111.46K222.91K334.37K445.83KUSD Trades VolumeJunJulAugSepOctNovDec2026FebMarAprMayJun
Insider Trading
InsiderRelationshipDateTransactionCost#SharesValue ($)#Shares TotalSEC Form 4
Minan Peter FrancisDirectorJun 09 '26Buy61.5028817,7123,211Jun 10 12:00 AM
Minan Peter FrancisDirectorJun 08 '26Buy63.1449231,0652,923Jun 10 12:00 AM
REEVE GRAHAM D.COOMar 11 '26Sale78.8666252,20530,078Mar 12 12:00 AM
REEVE GRAHAM D.COOMar 09 '26Sale78.521790Mar 11 12:00 AM
REEVE GRAHAM D.COOMar 06 '26Sale82.251,807148,6261Mar 11 12:00 AM
Binstein RichardEVP Gen'l Counsel & SecretaryMar 06 '26Sale81.643,000244,92024,867Mar 09 12:00 AM
REEVE GRAHAM D.COONov 24 '25Sale71.0174352,76020,740Nov 25 12:00 AM
Gilmartin Kathleen ADirectorNov 20 '25Buy69.004,000276,00024,786Nov 24 12:00 AM
HAM NANCYDirectorSep 11 '25Sale81.7160049,0261,994Sep 11 12:00 AM
Williams Eric JosephPresident and COOSep 05 '25Sale85.251,00085,25025,331Sep 08 12:00 AM
READING CHRISTOPHER JChairman of the Board and CEOSep 04 '25Sale83.532,000167,060114,088Sep 05 12:00 AM
HENDRICKSON CAREY PChief Financial OfficerAug 25 '25Sale86.1169860,10527,808Aug 25 12:00 AM
REEVE GRAHAM D.COOAug 21 '25Sale84.9776364,83221,483Aug 21 12:00 AM
REEVE GRAHAM D.COOAug 11 '25Sale86.571,792155,13322,246Aug 12 12:00 AM
HAM NANCYDirectorJun 12 '25Sale78.0140031,2042,594Jun 13 12:00 AM
open in yahoo·open in reuters·open in marketwatch·open in google·open in EDGAR